MAAR charts launched this week

  • Home
  • News
  • MAAR charts launched this week
Add to CPD Start a discussion

New pan London Medicines Authorisation & Administration Record (MAAR) charts in use as of 17/08/2020

What are these MAAR used for?

  • They are used for all injectable medicines used in End of Life Care in patients in the community – both adults and children. They cannot be used for any oral or patch medicines.
  • They need to be completed by prescribers e.g. GPs or NMPs to authorise appropriate health care professionals e.g. the adult community nursing team or nursing home staff to administer these medicines. Administration of all doses must then be recorded on the charts

How does this chart differ from the current St Jos chart?

  • The current charts are  used to authorise medicines  whereas these are combined authorisation and administration charts
  • There are 3 parts to this chart, the first 2 are very similar to the current authorisation chart
    • 24 hour subcutaneous infusions
    • PRN doses
    • Regular and crisis meds – this is a new section so this is where there might  be some confusion  

How can I find a copy of the MAAR chart and further information?

  • The chart will be uploaded onto EMIS in all C&H practices and has been tested
  • There is a copy of the chart and supporting documents  including FAQs on the GP intranet
  • A webinar involving the medical director for St Joseph’s hospice  explaining the chart can  also be found  on the GP intranet

What is allowed in terms of the authorisation and sending  of  the MAAR?

  • The chart can be completed in EMIS, printed off and the prescriber then signs the paper copy. This then needs to be scanned and emailed to the nursing team. As a wet signature has been used, this can be sent from any secure email account in the practice e.g. the generic practice Using a wet signature is considered to be the ideal option and is recommended in the supporting documentation of the new MAAR.
  • The chart can be totally completed in EMIS adding in both the GMC/NMC/GPHC number and a digital signature. To ensure there is accountability for this authorisation then the chart must be sent from the secure email account of that named prescriber. Alternatively, it can also be sent using AccuRx securely within EMIS.
  •  N.B. the documents circulated with the MAAR allude to the fact that in exceptional circumstances the prescriber can type in their name. This is not being accepted in C&H as there is a concern that some nurses will not accept this which could lead to delays. The guidance which supports this is here.


Expiry date: Aug 8th, 2022